Insider Transactions in Q1 2025 at Sangamo Therapeutics, Inc (SGMO)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 25
2025
|
Sandy Macrae PRESIDENT, CEO AND DIRECTOR |
BUY
Grant, award, or other acquisition
|
Direct |
375,000
+13.26%
|
-
|
|
Feb 25
2025
|
Sandy Macrae PRESIDENT, CEO AND DIRECTOR |
SELL
Payment of exercise price or tax liability
|
Direct |
10,663
-0.51%
|
$0
$0.96 P/Share
|
|
Feb 25
2025
|
Prathyusha Duraibabu SVP, CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
120,000
+12.88%
|
-
|
|
Feb 25
2025
|
Prathyusha Duraibabu SVP, CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
1,375
-0.2%
|
$0
$0.96 P/Share
|
|
Feb 25
2025
|
Scott B. Willoughby SVP, GEN. COUNSEL & SECRETARY |
BUY
Grant, award, or other acquisition
|
Direct |
120,000
+12.84%
|
-
|
|
Feb 25
2025
|
Scott B. Willoughby SVP, GEN. COUNSEL & SECRETARY |
SELL
Payment of exercise price or tax liability
|
Direct |
1,375
-0.2%
|
$0
$0.96 P/Share
|
|
Feb 25
2025
|
Nathalie Dubois Stringfellow SVP-CHIEF DEVELOPMENT OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
120,000
+12.59%
|
-
|
|
Feb 25
2025
|
Nathalie Dubois Stringfellow SVP-CHIEF DEVELOPMENT OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
1,513
-0.21%
|
$0
$0.96 P/Share
|
|
Feb 25
2025
|
Gregory D Davis Head of Research & Technology |
BUY
Grant, award, or other acquisition
|
Direct |
49,726
+18.71%
|
-
|
|
Feb 25
2025
|
Gregory D Davis Head of Research & Technology |
SELL
Payment of exercise price or tax liability
|
Direct |
507
-0.3%
|
$0
$0.96 P/Share
|
|
Feb 24
2025
|
Sandy Macrae PRESIDENT, CEO AND DIRECTOR |
SELL
Payment of exercise price or tax liability
|
Direct |
7,488
-0.36%
|
$7,488
$1.0 P/Share
|
|
Feb 24
2025
|
Prathyusha Duraibabu SVP, CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
1,792
-0.26%
|
$1,792
$1.0 P/Share
|
|
Feb 24
2025
|
Scott B. Willoughby SVP, GEN. COUNSEL & SECRETARY |
SELL
Payment of exercise price or tax liability
|
Direct |
1,434
-0.21%
|
$1,434
$1.0 P/Share
|
|
Feb 24
2025
|
Nathalie Dubois Stringfellow SVP-CHIEF DEVELOPMENT OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
1,792
-0.25%
|
$1,792
$1.0 P/Share
|
|
Feb 24
2025
|
Gregory D Davis Head of Research & Technology |
SELL
Payment of exercise price or tax liability
|
Direct |
705
-0.42%
|
$705
$1.0 P/Share
|
|
Jan 22
2025
|
Sandy Macrae PRESIDENT, CEO AND DIRECTOR |
SELL
Payment of exercise price or tax liability
|
Direct |
412,584
-16.45%
|
$412,584
$1.15 P/Share
|
|
Jan 22
2025
|
Prathyusha Duraibabu SVP, CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
129,242
-15.68%
|
$129,242
$1.15 P/Share
|
|
Jan 22
2025
|
Scott B. Willoughby SVP, GEN. COUNSEL & SECRETARY |
SELL
Payment of exercise price or tax liability
|
Direct |
129,549
-15.66%
|
$129,549
$1.15 P/Share
|
|
Jan 22
2025
|
Nathalie Dubois Stringfellow SVP-CHIEF DEVELOPMENT OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
129,593
-15.31%
|
$129,593
$1.15 P/Share
|
|
Jan 22
2025
|
Gregory D Davis Head of Research & Technology |
SELL
Payment of exercise price or tax liability
|
Direct |
30,456
-15.38%
|
$30,456
$1.15 P/Share
|